From September, Dr Baselga combines the scientific management of the Vall d’Hebron Institute of Oncology (VHIO) with his new appointment at the Hematology & Medical Oncology Division at the Cancer Center of the Massachusetts General Hospital at Harvard Medical School in Boston.
Related Posts
Hot off the press: VHIO´s 2014 Scientific Report now available
VHIO´s 2014 Scientific Report is now available either as a PDF (´light´version), or in its extended version online at: /scientific_reports/en_2014.php. Aside…
12 May 2015
VHIO tries out a new diagnostic test that detects HER2 fragments in breast cancer
Approximately 30% of all breast cancers currently diagnosed have a genetic abnormality
07 Sep 2010
A date with The Lancet Oncology: Friday 26 July 2013
David Collingridge, Editor-in-Chief of The Lancet Oncology will deliver the next in VHIO´s Meet the Editor series of talks: Insights…
31 May 2013
Driving a novel therapy against glioblastoma: VHIO´s Laura Soucek awarded BBVA Foundation Grant to validate peptides targeting Myc
• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…
09 Oct 2015
VHIO Spin-Off Mosaic Biomedicals co-recipient of CataloniaBio´s Biosuccess Award of the Year
Wednesday night´s annual Night of CataloniaBio gala event convening some 250 entrepreneurs, executives, investors, and leading scientists from within the…
17 Mar 2017
Molecular Oncology News and Views: VHIO-Fritz Bender Foundation International Symposium on Progress Towards Individualized Cancer Treatments, 07 – 09 November 2013
Molecular Oncology 8 (2014) 1-8 News and views Towards individualized cancer therapy: Challenges and prospects Ezzie Hutchinson ABSTRACT At the…
14 Feb 2014
VHIO scientists eradicate lung tumours in a pre-clinical mouse model
Previous studies had already shown that Myc was a key protein in tumour development and had established how to inhibit…
09 Mar 2013
Josep Tabernero listed among the Highly Cited Researchers 2016: representing some of the world´s most influential scientific minds
In the recently announced Highly Cited Researcher listing 2016 by Clarivate Analytics – formerly the IP & Science business of…
21 Nov 2016
Discovery of a new gene responsible for colon cancer
José Baselga and Josep Tabernero directly participate in the study, directed by William Hahn, of the Dana-Farber Cancer Institute of Boston
07 Sep 2010
ecancer TV´s interview with Joan Seoane: driving discovery to more precisely characterize, track and treat glioblastoma
During the recently celebrated 24th Biennial Congress of the European Association for Cancer Research (EACR), 09 – 12 July, Manchester…
25 Jul 2016
Nature Reviews Cancer Perspectives/Opinion article: an exploration of the precise and predictive powers of PDX models – now and in the future
In a recent Perspectives/Opinion article* published online in Nature Reviews Cancer, members of the EurOPDX Consortium, including VHIO´s Joaquín Arribas,…
16 Feb 2017
Gene-panel sequencing spurs improved diagnosis of hereditary cancer
Between 50 – 75% of the most common hereditary cancers (breast and colon) escape the diagnostic ´lens´ when only factoring…
02 Nov 2015
Oncology channel ecancer catches up with VHIO´s Elena Garralda and Cristina Saura during last week´s ESMO Congress
During last week´s ESMO Congress celebrated in Madrid 08 – 12 September, oncology channel ecancer TV interviewed Elena Garralda, Executive…
14 Sep 2017
VHIO on the ground and delivering data at San Antonio Breast Cancer Symposium 2016
Now in its 39th annual edition, the San Antonio Breast Cancer Symposium (SABCS) is the world´s largest, multidisciplinary breast cancer…
08 Dec 2016
VHIO´s Laura Soucek receives ICREA professorship to further spur research of excellence at International level
ICREA – the Catalan Institution for Research and Advanced Studies, founded in 2001 with the support of the Catalan Government,…
19 Jan 2015
